" I LOST MY MOTHER TO OVARIAN CANCER.
I DON'T WANT YOU TO LOSE YOURS, TOO".
For the 10th year, Georg Jensen continues to partner with the Ovarian Cancer Research Foundation (OCRF), Australia's leading
independent funder of ovarian cancer research. This enduring commitment is a testament to Georg Jensen's legacy in providing
sustained funding for critical research that can help better detect, treat and prevent ovarian cancer.
This year, Georg Jensen introduces the 2024 campaign, Untold Stories. We share the poignant personal story of
OCRF ambassador Suki Paddington, alongside her husband Kevin and their son Kai. Suki and her family
faced an unimaginable loss when her mother, Margy, was tragically taken by ovarian cancer in 2023.
In telling Margy's story, Suki honours her mother's legacy, raises awareness, and preserves her memory. Margy's
loss was a profound injustice. No life should be cut short by ovarian cancer - women and families deserve better.
These are the Untold Stories of ovarian cancer.
Know the facts:
In Australia, five new cases of ovarian cancer are diagnosed each day, and this number continues to
rise. Tragically, we lose more than 1,000 women and girls to ovarian cancer annually, equating to one
life lost every eight hours. Despite this, ovarian cancer remains chronically underfunded.
By purchasing the OCRF Pendant, you contribute directly to the research that is vital for improving
treatment and finding an early detection method for this devastating disease.
Feature Pendants
The original "Forget-Me-Knot" design features a thin strand of gold intertwined into organic
shapes, giving life to a unique and elegant piece. Vivianna Torun designed the
Forget-Me-Knot to remind the wearer never to forget herself, and this timeless inspiration has
been beautifully extended to embrace the collective cause of the Ovarian Cancer Research
Foundation, honouring family members and friends affected by ovarian cancer.
For every purchase of the OCRF Pendant, a portion of the proceeds is donated by Georg
Jensen directly to the OCRF, supporting critical research to advance treatment methods and
improve early detection of ovarian cancer.